US$ 20.63
glp 1 drugs depression GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective The GLP-1 Agonists and Obesity:
Description
This licensing arrangement has pros and cons

Intriguingly, beyond their metabolic benefits, GLP-1RAs also exhibit anti-inflammatory effects

Apart from being more affordable, the new version is expected to have wider appeal by being needle free and easier for the patient to fit into their routine

The company that wins here could set the tone for pharmas next decade, and investors know it

Over time, this could cause overweight or obesity